Literature DB >> 2897775

Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology.

D Raoult1, J Urvölgyi, J Etienne, M Roturier, J Puel, H Chaudet.   

Abstract

The authors compared two groups of 20 patients suffering from Q fever using microimmunofluorescence (micro IF) serology. One group had endocarditis and the other conventional symptoms of acute Q fever but no endocarditis. Determination of the levels of antibodies against the two phases of rickettsiae in each of the three immunoglobulin classes (IgG, IgM and IgA), allowed to determine the type of infection using a single serum sample. Patients having IgA class antiphase I antibodies at a level equal to/or higher than 1:25 as well as those whose antibody levels fulfilled the conditions for the equation (IgG anti-phase I greater than or equal to IgG anti-phase II) + (IgA anti-phase I greater than or equal to IgA anti-phase II) were suffering from endocarditis. The positive predictive value of these tests was 100% and 94.1%, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897775

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  11 in total

1.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Clinical evaluation of a new PCR assay for detection of Coxiella burnetii in human serum samples.

Authors:  G Q Zhang; S V Nguyen; H To; M Ogawa; A Hotta; T Yamaguchi; H J Kim; H Fukushi; K Hirai
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  Combined determination of Coxiella burnetii-specific immunoglobulin M (IgM) and IgA improves specificity in the diagnosis of acute Q fever.

Authors:  P Devine; C Doyle; G Lambkin
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

Review 4.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 5.  Treatment of Q fever.

Authors:  D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

6.  Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations.

Authors:  S Reilly; J L Northwood; E O Caul
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

7.  Coxiella burnetii infection among subjects infected with HIV type 1 in the Central African Republic.

Authors:  L Bélec; G Grésenguet; M T Ekala; A Jacob; M D Vohito; S Cotigny; C Payan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

8.  Serological differentiation between acute (late control) and endocarditis Q fever.

Authors:  F Soriano; M T Camacho; C Ponte; P Gómez
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

9.  Direct identification of Coxiella burnetii plasmids in human sera by nested PCR.

Authors:  G Q Zhang; A Hotta; M Mizutani; T Ho; T Yamaguchi; H Fukushi; K Hirai
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

10.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.